Malley Thomas (CIK 0001403322)

Latest company ownership

TPST - Tempest Therapeutics, Inc.

Role: Director

Shares held

204,981

Last filed at

Jul 5, 2017

Confidence Score

50.0

2025Q4

Confidence Score History

2013Q1 2025Q4

KURA - Kura Oncology, Inc.

Role: Director

Shares held

139,557

Last filed at

Jun 21, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2015Q4 2025Q4

Role: Director

Shares held

71,967

Last filed at

May 29, 2018

Confidence Score

43.7

2025Q4

Confidence Score History

2025Q3 2025Q4

PBYI - PUMA BIOTECHNOLOGY, INC.

Role: Director

Shares held

10,000

Last filed at

Dec 16, 2014

Confidence Score

50.0

2025Q4

Confidence Score History

2012Q2 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Aug 12, 2025	Aug 14, 2025	Kiniksa Pharmaceuticals International, plc	Director	Sell	16.3	-177,769	-61.86%	✗	$5.9M
Jun 16, 2023	Jun 21, 2023	Kura Oncology, Inc.	Director	Buy	97.5	+50,000	55.83%	✗	$575K
Nov 10, 2015	Dec 17, 2015	Kura Oncology, Inc.	Director	Buy	97.5	+50,000	126.40%	✗	$400K
Apr 8, 2015	Apr 9, 2015	Tempest Therapeutics, Inc.	Director	Buy	87.5	+5,000	4.27%	✗	$142.5K
Jan 13, 2015	Jan 15, 2015	Tempest Therapeutics, Inc.	Director	Buy	100.0	+35,000	42.78%	✗	$1.8M
Mar 18, 2013	Mar 20, 2013	Tempest Therapeutics, Inc.	Director	Buy	97.5	+50,000	157.14%	✗	$450K
Oct 24, 2012	Oct 25, 2012	PUMA BIOTECHNOLOGY, INC.	Director	Buy	90.0	+10,000	6.82%	✗	$160K
Jun 11, 2012	Jun 13, 2012	PUMA BIOTECHNOLOGY, INC.	Director	Buy	90.0	+10,032	7.35%	✗	$125.4K
Jun 7, 2012	Jun 11, 2012	PUMA BIOTECHNOLOGY, INC.	Director	Buy	90.0	+9,968	7.88%	✗	$124.6K